Skip to main content

Table 1 Baseline characteristics of mildly depressed patients with type 2 diabetes who entered treatment.

From: Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: A double-blind randomised placebo controlled 6-month trial

  Placebo (n = 20) Paroxetine (n = 23)
  Mean SD Mean SD
Sex (M/F) 16/4   17/6  
Age (years) 59.5 6.0 59.2 5.4
Body mass index (kg/m2) 32.0 5.3 31.7 5.5
Metabolic parameters     
GHbA1c (%) 8.7 1.3 8.5 0.9
Fasting serum glucose (mmol/l) 10.4 3.4 10.4 3.7
Serum C-Peptide (nmol/l) 0.69 0.53 0.74 0.91
Sex hormone binding globulin (nmol/l) 43.2 23.1 37.0 18.7
Mental status     
Hospital Anxiety and Depression Scale total score 15.7 5.5 14.0 5.2
Hospital Anxiety and Depression Scale depression score 8.4 3.4 7.3 3.4
Hospital Anxiety and Depression Scale anxiety score 7.3 3.0 6.7 2.6
SF-36 composite score 48.5 15.7 56.2 17.4